The role of high-risk HPV and HPV-16 variants and of hTERT, IGF1R<i>α</i>, IGF1R<i>β</i>, CAIX, and GLUT1 variations seemed confirmed in the development and progression of cervical cancer. This evidence concerns the gene SLC2A1 and cervical carcinoma.